These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17392321)
1. Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Ottenheijm CA; Jenniskens GJ; Geraedts MC; Hafmans T; Heunks LM; van Kuppevelt TH; Dekhuijzen PN Eur Respir J; 2007 Jul; 30(1):80-9. PubMed ID: 17392321 [TBL] [Abstract][Full Text] [Related]
2. Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. Lensen JF; Rops AL; Wijnhoven TJ; Hafmans T; Feitz WF; Oosterwijk E; Banas B; Bindels RJ; van den Heuvel LP; van der Vlag J; Berden JH; van Kuppevelt TH J Am Soc Nephrol; 2005 May; 16(5):1279-88. PubMed ID: 15788473 [TBL] [Abstract][Full Text] [Related]
3. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. Ottenheijm CA; Heunks LM; Dekhuijzen PN Am J Respir Crit Care Med; 2007 Jun; 175(12):1233-40. PubMed ID: 17413128 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of heparan sulfates in human lung. Smits NC; Robbesom AA; Versteeg EM; van de Westerlo EM; Dekhuijzen PN; van Kuppevelt TH Am J Respir Cell Mol Biol; 2004 Feb; 30(2):166-73. PubMed ID: 12896874 [TBL] [Abstract][Full Text] [Related]
5. Acute Exacerbations of COPD Are Associated With Increased Expression of Heparan Sulfate and Chondroitin Sulfate in BAL. Papakonstantinou E; Klagas I; Roth M; Tamm M; Stolz D Chest; 2016 Mar; 149(3):685-95. PubMed ID: 26226327 [TBL] [Abstract][Full Text] [Related]
6. Distribution of costameric proteins in the diaphragm of patients with chronic obstructive pulmonary disease. Wijnhoven JH; Hafmans T; Dekhuijzen PN Respiration; 2006; 73(4):529-37. PubMed ID: 16449803 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Barreiro E; de la Puente B; Minguella J; Corominas JM; Serrano S; Hussain SN; Gea J Am J Respir Crit Care Med; 2005 May; 171(10):1116-24. PubMed ID: 15735057 [TBL] [Abstract][Full Text] [Related]
8. Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Smits NC; Lensen JF; Wijnhoven TJ; Ten Dam GB; Jenniskens GJ; van Kuppevelt TH Methods Enzymol; 2006; 416():61-87. PubMed ID: 17113860 [TBL] [Abstract][Full Text] [Related]
9. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Testelmans D; Crul T; Maes K; Agten A; Crombach M; Decramer M; Gayan-Ramirez G Eur Respir J; 2010 Mar; 35(3):549-56. PubMed ID: 19717478 [TBL] [Abstract][Full Text] [Related]
10. [Diaphragm dysfunction in patients with chronic obstructive pulmonary disease]. Verheul AJ; Dekhuijzen PN Ned Tijdschr Geneeskd; 2003 May; 147(18):855-60. PubMed ID: 12756876 [TBL] [Abstract][Full Text] [Related]
11. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Smetsers TF; van de Westerlo EM; ten Dam GB; Clarijs R; Versteeg EM; van Geloof WL; Veerkamp JH; van Muijen GN; van Kuppevelt TH Cancer Res; 2003 Jun; 63(11):2965-70. PubMed ID: 12782604 [TBL] [Abstract][Full Text] [Related]
12. Altered composition of urinary heparan sulfate in patients with COPD. van de Lest CH; Versteeg EM; Veerkamp JH; Berden JH; van den Born J; Heunks L; Lammers JW; van Herwaarden CL; Dekhuijzen PN; van Kuppevelt TH Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):952-8. PubMed ID: 8887591 [TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane. van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920 [TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Santos S; Peinado VI; Ramirez J; Morales-Blanhir J; Bastos R; Roca J; Rodriguez-Roisin R; Barbera JA Am J Respir Crit Care Med; 2003 May; 167(9):1250-6. PubMed ID: 12615615 [TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products. Tumova S; Hatch BA; Law DJ; Bame KJ Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290 [TBL] [Abstract][Full Text] [Related]
16. Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease. Kim HC; Mofarrahi M; Vassilakopoulos T; Maltais F; Sigala I; Debigare R; Bellenis I; Hussain SN Am J Respir Crit Care Med; 2010 Apr; 181(8):797-805. PubMed ID: 20110558 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Zandvoort A; Postma DS; Jonker MR; Noordhoek JA; Vos JT; van der Geld YM; Timens W Eur Respir J; 2006 Sep; 28(3):533-41. PubMed ID: 16707515 [TBL] [Abstract][Full Text] [Related]
18. A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Baldwin RJ; ten Dam GB; van Kuppevelt TH; Lacaud G; Gallagher JT; Kouskoff V; Merry CL Stem Cells; 2008 Dec; 26(12):3108-18. PubMed ID: 18787209 [TBL] [Abstract][Full Text] [Related]
19. Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains. Deakin JA; Lyon M J Cell Sci; 1999 Jun; 112 ( Pt 12)():1999-2009. PubMed ID: 10341217 [TBL] [Abstract][Full Text] [Related]